Coronavirus Update: Regeneron's REGEN-COV Authorized For Prevention

Regeneron's antibody cocktail gets emergency authorization for post-exposure prophylaxis from the US FDA. Daewoong's camostat shows efficacy in older patients in South Korean trial. 

3D_Coronavirus

More from COVID-19

More from Scrip